Exchange Traded Concepts LLC Cuts Stock Position in Encompass Health Corporation (NYSE:EHC)

Exchange Traded Concepts LLC lessened its holdings in Encompass Health Corporation (NYSE:EHC) by 2.7% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 7,943 shares of the company’s stock after selling 221 shares during the period. Exchange Traded Concepts LLC’s holdings in Encompass Health were worth $804,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Fifth Third Bancorp grew its position in shares of Encompass Health by 88.7% during the first quarter. Fifth Third Bancorp now owns 4,290 shares of the company’s stock valued at $434,000 after purchasing an additional 2,017 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Encompass Health by 737.0% during the first quarter. SG Americas Securities LLC now owns 25,084 shares of the company’s stock valued at $2,541,000 after purchasing an additional 22,087 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Encompass Health by 21.5% during the first quarter. GAMMA Investing LLC now owns 2,366 shares of the company’s stock valued at $240,000 after purchasing an additional 419 shares in the last quarter. Park Avenue Securities LLC grew its position in shares of Encompass Health by 5.7% during the first quarter. Park Avenue Securities LLC now owns 7,123 shares of the company’s stock valued at $721,000 after purchasing an additional 386 shares in the last quarter. Finally, OLD National Bancorp IN purchased a new position in shares of Encompass Health during the first quarter valued at about $203,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

EHC has been the subject of several recent research reports. Royal Bank Of Canada lifted their price target on Encompass Health from $110.00 to $125.00 and gave the stock an “outperform” rating in a research report on Monday, April 28th. Stephens upgraded Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 price target for the company in a research report on Thursday, June 5th. Wall Street Zen lowered Encompass Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 6th. KeyCorp lifted their price target on Encompass Health from $122.00 to $135.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 27th. Finally, Barclays raised their price objective on shares of Encompass Health from $118.00 to $129.00 and gave the stock an “overweight” rating in a research note on Friday, April 25th. Eight equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Encompass Health presently has a consensus rating of “Buy” and a consensus target price of $127.00.

Encompass Health Stock Performance

Encompass Health stock opened at $119.07 on Friday. The company has a 50 day moving average price of $115.81 and a 200-day moving average price of $103.98. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.06 and a current ratio of 1.06. Encompass Health Corporation has a fifty-two week low of $82.74 and a fifty-two week high of $123.13. The company has a market capitalization of $12.00 billion, a PE ratio of 24.60, a P/E/G ratio of 2.43 and a beta of 0.89.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the previous year, the firm posted $1.12 earnings per share. The company’s revenue was up 10.6% on a year-over-year basis. As a group, equities analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health’s dividend payout ratio (DPR) is 14.05%.

Insider Buying and Selling

In other news, CEO Mark J. Tarr sold 118,384 shares of the company’s stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the transaction, the chief executive officer now directly owns 527,070 shares of the company’s stock, valued at approximately $64,054,817.10. This represents a 18.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the company’s stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider now directly owns 11,958 shares in the company, valued at approximately $1,394,422.38. The trade was a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 132,663 shares of company stock valued at $16,034,082 over the last 90 days. Corporate insiders own 2.00% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.